可注射的CRISPRa微球用于有针对性的A20激活,通过衰老缓解来拯救与年龄相关的骨质性损伤

相关实验视频

Updated: Jan 11, 2026

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

Jie Chen¹, Zhen Wang¹, Yawei Du¹

¹Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, PR China.

|November 10, 2025

概括

工程基因编辑微球 (GEMs) 成功重编程老化的干细胞以增强骨修复. 这种新的方法针对炎症和衰老,在老年骨缺陷中促进显著的骨再生和血管化.

科学领域:

生物医学工程生物医学工程
再生医学是一种再生医学.
干细胞生物学干细胞生物学

背景情况:

与年龄相关的骨缺陷修复受到慢性炎症和干细胞衰老的阻碍.
老化损害了骨髓 stromal 细胞 (BMSCs) 的骨质生成潜力.

研究的目的:

开发一种可注射的基因编辑系统,用于在老年BMSC中激活TNFAIP3/A20.
研究A20在调节衰老和骨质生成中的作用.
评估该系统在促进老年小鼠骨再生方面的有效性.

主要方法:

使用微流体合成的脂质纳米颗粒 (cLNP) 制造基于CRISPRa的基因编辑微球 (GEM).
同时提供dCas9-VP64/sgRNA用于TNFAIP3/A20的时空激活.
在体外评估衰老标记物,骨质基因表达和炎症性细胞因子.
在老鼠模型中对骨再生和血管化的体内评估,老鼠模型具有关键大小的骨缺陷.

主要成果:

在体外,GEM显著降低了衰老标志物 (p16,p21) 和抑制了炎症性细胞因子 (IL-6,TNF-α).
在实验室中,GEMs增加了骨质基因表达 (RUNX2,ALP) 的4-5倍.
在体内,GEM加速了骨再生和血管化 (3.1倍更快),在老年小鼠中达到80%的缺陷愈合.

结论:

A20是老化相关分泌表型 (SASP) 和老年BMSCs骨质性衰竭的关键调节者.
该GEM系统提供了一个有前途的战略,用于在现场重新编程老化的干细胞.
这种方法为与年龄相关的骨疾病和骨缺陷修复提供了临床可行的解决方案.

关键词:

A20/TNFAIP3 美国与年龄相关的骨缺陷在CRISPR中激活CRISPR.可以注射的水凝.衰老 - 骨质生成轴

更多相关视频

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids

Published on: May 16, 2025

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...